Post-Merger Integration for Life Sciences

Publish date:

Realizing synergies and maximizing value through post-merger integration. Another wave of consolidation is hitting the life sciences industry. In 2009, a combination of mega-mergers, diversification plays and tuck-in acquisitions have characterized the merger and acquisition (M&A) landscape in the pharmaceutical sector. The trend is expected to continue as CEOs respond to industry pressures and opportunities […]

Realizing synergies and maximizing value through post-merger integration.

Another wave of consolidation is hitting the life sciences industry. In 2009, a combination of mega-mergers, diversification plays and tuck-in acquisitions have characterized the merger and acquisition (M&A) landscape in the pharmaceutical sector. The trend is expected to continue as CEOs respond to industry pressures and opportunities to create value through M&A and divestitures. However, it is still unclear whether these transactions ever fulfill the value they promise.

Related Resources

The secret to scaling Artificial Intelligence

Tune in to our podcast for a glimpse into where AI is today and how far it might take us...

Balance by Design

Among this time of disruption and discontinuity, ‘Balance by design’ aims to help...

We Collaborate

It’s time to tap into the phenomenal power of the collaborative Technology Business, even as...